World Wires · Story 98389 · unverified · 1 Quelle(n)

First Human Administration of Senolytic Immunotherapy to Fight Cellular Aging Announced by Immorta Bio

First patient receives SenoMune™-0257, a pioneering immunotherapy designed to eliminate aging cells and advance treatment of age-related diseases MIAMI, No

Im Desk öffnen

Berichterstattung

Was diese Seite indexiert